PHARMACOKINETICS OF PIRENZEPINE IN HEPATIC INSUFFICIENCY AND COMBINED RENAL-HEPATIC INSUFFICIENCY

被引:0
|
作者
KRAKAMP, B
LEIDIG, P
TANSWELL, P
SCHMITZ, R
BOZLER, G
机构
[1] DR KARL THOMAE GMBH,DEPT BIOCHEM,D-7950 BIBERACH,FED REP GER
[2] UNIV COLOGNE,LEHRSTUHL CHIRURG 2,D-5000 COLOGNE 41,FED REP GER
[3] STADT KRANKENANSTALTEN KOLN,KRANKENHAUS MERHEIM,MED KLIN 1,KOLN,FED REP GER
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:S391 / S391
页数:1
相关论文
共 50 条
  • [1] STEADY-STATE INTRAVENOUS PHARMACOKINETICS OF PIRENZEPINE IN PATIENTS WITH HEPATIC INSUFFICIENCY AND COMBINED RENAL-INSUFFICIENCY AND HEPATIC-INSUFFICIENCY
    KRAKAMP, B
    TANSWELL, P
    LEIDIG, P
    VOGEL, H
    SCHMITZ, R
    BOZLER, G
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 36 (01) : 71 - 73
  • [2] The pharmacokinetics of ropivacaine in hepatic and renal insufficiency
    Jokinen, Mika J.
    BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY, 2005, 19 (02) : 269 - 274
  • [3] Pharmacokinetics of 'Seroquel' (quetiapine) in hepatic and renal insufficiency
    Wong, YWJ
    Ewing, BJ
    Thyrum, PT
    Yeh, C
    SCHIZOPHRENIA RESEARCH, 1997, 24 (1-2) : 200 - 200
  • [4] Renal insufficiency in patients with hepatic insufficiency
    Lenz, K.
    Binder, M.
    Buder, R.
    Gruber, A.
    Gutschreiter, B.
    Voglmayr, M.
    MEDIZINISCHE KLINIK-INTENSIVMEDIZIN UND NOTFALLMEDIZIN, 2014, 109 (04) : 240 - 245
  • [5] MEZLOCILLIN PHARMACOKINETICS IN HEPATIC INSUFFICIENCY
    BUNKE, CM
    ARONOFF, GR
    BRIER, ME
    SLOAN, RS
    LUFT, FC
    CLINICAL RESEARCH, 1982, 30 (04): : A717 - A717
  • [6] PHARMACOKINETICS OF DIHYDROERGOTAMINE IN HEPATIC INSUFFICIENCY
    LABAYLE, D
    CHALAS, J
    LAVENE, D
    KIECHEL, JR
    LINDENBAUM, A
    CHAPUT, JC
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1980, 4 (12): : 923 - 923
  • [7] Pharmacokinetics of ondansetron in patients with hepatic insufficiency
    Figg, WD
    Dukes, GE
    Pritchard, JF
    Hermann, DJ
    Lesesne, HR
    Carson, SW
    Songer, SS
    Powell, R
    Hak, LJ
    JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 36 (03): : 206 - 215
  • [8] The effect of hepatic insufficiency on the pharmacokinetics of ridaforolimus
    McCrea, J. B.
    Stroh, M.
    Li, X.
    Schulz, V.
    Talaty, J.
    Orford, K. W.
    Trucksis, M.
    Lasseter, K.
    Agrawal, N.
    Wagner, J. A.
    Iwamoto, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [9] Lack of a Clinically Important Effect of Moderate Hepatic Insufficiency and Severe Renal Insufficiency on Raltegravir Pharmacokinetics
    Iwamoto, Marian
    Hanley, William D.
    Petry, Amelia S.
    Friedman, Evan J.
    Kost, James T.
    Breidinger, Sheila A.
    Lasseter, Kenneth C.
    Robson, Richard
    Lunde, Norman M.
    Wenning, Larissa A.
    Stone, Julie A.
    Wagner, John A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (05) : 1747 - 1752
  • [10] ALTERATION OF THE KINETICS OF TOCAINIDE IN COMBINED HEPATIC AND RENAL-INSUFFICIENCY
    ENDELL, W
    OLTMANNS, D
    POTTAGE, T
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1983, 5 (08): : 589 - 590